Trajectory of COVID-19 vaccine hesitancy post-vaccination and public’s intention to take booster vaccines: A cross-sectional analysis

Author:

Salman Muhammad1,Mallhi Tauqeer Hussain2,Khan Yusra Habib2,Mustafa Zia Ul3,Khan Muhammad Tanveer1,Khan Faiz Ullah4,Butt Muhammad Hammad5ORCID,Shehzadi Naureen6,Farrukh Muhammad Junaid7,Waheed Maria8,Azmat Fatima8,Saeed Areej8,Mazhar Syeda Ayesha8,Ali Asim8,Ashfaq Aisha8,Hussain Khalid6

Affiliation:

1. Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Lahore, Pakistan

2. Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Kingdom of Saudi Arabia

3. Department of Pharmacy Services, District Headquarter Hospital, Pakpattan, Pakistan

4. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an, China

5. Department of Medicinal Chemistry, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden

6. Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan

7. Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia

8. Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3